Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Convertible Debt (2021 - 2025)

Beauty Health (SKIN) has disclosed Convertible Debt for 5 consecutive years, with $363.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Convertible Debt fell 34.1% to $363.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $363.4 million, a 34.1% decrease, with the full-year FY2024 number at $552.2 million, down 25.21% from a year prior.
  • Convertible Debt was $363.4 million for Q3 2025 at Beauty Health, roughly flat from $363.1 million in the prior quarter.
  • In the past five years, Convertible Debt ranged from a high of $738.4 million in Q4 2023 to a low of $363.1 million in Q2 2025.
  • A 5-year average of $643.3 million and a median of $729.9 million in 2021 define the central range for Convertible Debt.
  • Peak YoY movement for Convertible Debt: grew 0.58% in 2022, then crashed 34.1% in 2025.
  • Beauty Health's Convertible Debt stood at $729.9 million in 2021, then rose by 0.58% to $734.1 million in 2022, then rose by 0.58% to $738.4 million in 2023, then fell by 25.21% to $552.2 million in 2024, then tumbled by 34.19% to $363.4 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Convertible Debt are $363.4 million (Q3 2025), $363.1 million (Q2 2025), and $553.0 million (Q1 2025).